Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Four Biosimilar Pegfilgrastims Under EU Review After Sandoz Re-Submits Zioxtenzo
Nov 01 2017
•
By
Ian Schofield
Sandoz is having another crack at getting its biosimilar pegfilgrastim approved
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Biosimilars
More from Biosimilars & Generics